Rapid Bio at Eastern Economic Forum 2025: new opportunities for biotech and business

The Eastern Economic Forum (EEF) has once again brought together government officials, business leaders and researchers to discuss the future of Russia’s Far East and its role in the Asia-Pacific region. In 2025, the agenda included a strong focus on biotechnology, innovation and new market growth.

Rapid Bio’s Commercial Director and co-founder Semyon Pokatsky took part as a speaker in several key sessions at the forum:

• “Course to the East: Drivers of Biotech Growth” – a discussion on the Far East as a strategic platform for developing the bioeconomy, transferring technologies and promoting Russian biotech products to Asia-Pacific markets.
• “Incentives for Venture Market Growth: From Business Angels to IPOs” – a session focused on support mechanisms for start-ups, the evolution of the venture ecosystem and ways to increase the investment appeal of high-tech companies.
• “Business in Russian”, held under the auspices of the Russian “Znanie” (“Knowledge”) Society – a panel highlighting the experience of domestic brands that have grown from local initiatives into national leaders, and the challenges of scaling up and building an entrepreneurial support ecosystem in Russia.

In a panel discussion on improving the business climate, Semyon Pokatsky emphasised the importance of Russian innovation-driven companies that create new markets and contribute to the country’s technological sovereignty.

On the sidelines of the forum, Rapid Bio also held talks with partners from the Amur and Sakhalin regions, exploring possible areas of cooperation and joint projects in healthcare and diagnostics.

Participation in EEF 2025 has given Rapid Bio an additional platform to present itself as a fast-growing biotech company open to dialogue and collaboration with Russian regions and international partners alike.